Literature DB >> 16152734

Inhibition of chlamydia trachomatis growth by human interferon-alpha: mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha.

Tatsuya Ishihara1, Miho Aga, Keiko Hino, Chie Ushio, Mutsuko Taniguchi, Kanso Iwaki, Masao Ikeda, Masashi Kurimoto.   

Abstract

We have evaluated the effect of natural human interferon (IFN)-alpha on the growth of chlamydia trachomatis in human epithelial cells in vitro and revealed that IFN-alpha has reduced both growth and infectivity of C. trachomatis. The effect of IFN-alpha was reversed by the addition of exogenous L-tryptophan and iron to the culture medium, suggesting that antichlamydial effect of IFN-alpha was caused by depletion of intracellular tryptophan and iron, both of which are essential for chlamydial growth. When IFN-alpha was combined with another antichlamydial cytokines, IFN-gamma and tumor necrosis factor (TNF)-alpha, the effect was synergistically enhanced. Therefore, IFN-alpha would act coordinately with other cytokines such as IFN-gamma and TNF-alpha, and play an important role in host defense against infection and in the establishment of persistent chlamydial infection of host, in which the organism remains viable, but in a culture-negative state.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16152734     DOI: 10.2220/biomedres.26.179

Source DB:  PubMed          Journal:  Biomed Res        ISSN: 0388-6107            Impact factor:   1.203


  16 in total

1.  Tumour necrosis factor inhibition causing psoriasis? A more plausible explanation exists.

Authors:  J D Carter
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

2.  Treating reactive arthritis: insights for the clinician.

Authors:  John D Carter
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-02       Impact factor: 5.346

Review 3.  Effects of type I interferons in malaria.

Authors:  Ismail Sebina; Ashraful Haque
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

Review 4.  Type I interferon: friend or foe?

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

Review 5.  Type I interferons in infectious disease.

Authors:  Finlay McNab; Katrin Mayer-Barber; Alan Sher; Andreas Wack; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2015-02       Impact factor: 53.106

6.  Modulation of cytokines and transcription factors (T-Bet and GATA3) in CD4 enriched cervical cells of Chlamydia trachomatis infected fertile and infertile women upon stimulation with chlamydial inclusion membrane proteins B and C.

Authors:  Rishein Gupta; Harsh Vardhan; Pragya Srivastava; Sudha Salhan; Aruna Mittal
Journal:  Reprod Biol Endocrinol       Date:  2009-08-22       Impact factor: 5.211

Review 7.  Insights Into Host Cell Cytokines in Chlamydia Infection.

Authors:  Wenjing Xiang; Nanyan Yu; Aihua Lei; Xiaofang Li; Shui Tan; Lijun Huang; Zhou Zhou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

Review 8.  The role of innate immune signals in immunity to Brucella abortus.

Authors:  Marco Túlio R Gomes; Priscila C Campos; Leonardo A de Almeida; Fernanda S Oliveira; Miriam Maria S Costa; Fernanda M Marim; Guilherme S M Pereira; Sergio C Oliveira
Journal:  Front Cell Infect Microbiol       Date:  2012-10-25       Impact factor: 5.293

9.  STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection.

Authors:  Jeffrey R Barker; Benjamin J Koestler; Victoria K Carpenter; Dara L Burdette; Christopher M Waters; Russell E Vance; Raphael H Valdivia
Journal:  mBio       Date:  2013-04-30       Impact factor: 7.867

10.  Gene expression profiles of Chlamydophila pneumoniae during the developmental cycle and iron depletion-mediated persistence.

Authors:  André P Mäurer; Adrian Mehlitz; Hans J Mollenkopf; Thomas F Meyer
Journal:  PLoS Pathog       Date:  2007-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.